Here we found that tumor cell growth and tumor-induced Treg cell trafficking were increased in KMT2Dmut DLBCL, which could be subsequently counteracted by TGF-β inhibitor. This evidence concerns the gene TGFB1 and diffuse large B-cell lymphoma.